Clear Harbor Asset Management LLC Purchases New Stake in Aemetis, Inc. (NASDAQ:AMTX)

Clear Harbor Asset Management LLC purchased a new position in Aemetis, Inc. (NASDAQ:AMTX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 16,475 shares of the specialty chemicals company’s stock, valued at approximately $44,000.

A number of other hedge funds have also recently modified their holdings of AMTX. FMR LLC lifted its stake in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares during the period. Barclays PLC lifted its position in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares during the period. Rhumbline Advisers lifted its position in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares during the period. Geode Capital Management LLC boosted its stake in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares in the last quarter. Finally, Wellington Management Group LLP purchased a new position in shares of Aemetis during the third quarter valued at about $177,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Wall Street Analysts Forecast Growth

AMTX has been the topic of several research reports. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com upgraded Aemetis to a “sell” rating in a research report on Friday, January 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Stock Performance

Shares of NASDAQ AMTX opened at $2.15 on Thursday. The company has a 50 day simple moving average of $3.16 and a two-hundred day simple moving average of $2.95. Aemetis, Inc. has a fifty-two week low of $2.04 and a fifty-two week high of $7.03. The company has a market capitalization of $106.94 million, a price-to-earnings ratio of -0.95 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) EPS. On average, analysts forecast that Aemetis, Inc. will post -2.07 earnings per share for the current fiscal year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.